{"gene":"ARID1B","run_date":"2026-04-28T17:12:37","timeline":{"discoveries":[{"year":2002,"finding":"ARID1B (hELD/OSA1) directly binds BRG1 (SMARCA4) through its C-terminal EHD2 domain, and is incorporated into endogenous SWI/SNF complexes; the EHD1 and EHD2 domains can also interact with each other.","method":"Biochemical cloning, co-immunoprecipitation, domain mapping, detection of endogenous complex from mouse brain","journal":"The Biochemical Journal","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP with domain-mapping mutagenesis, endogenous complex detected","pmids":["11988099"],"is_preprint":false},{"year":2008,"finding":"BAF250B (ARID1B)-associated SWI/SNF complex is required for mouse embryonic stem cell self-renewal and normal proliferation; biallelic inactivation of BAF250B reduces pluripotency gene expression and causes aberrant cell cycle.","method":"Biallelic knockout of BAF250B in mouse ES cells, colony/proliferation assays, gene expression analysis","journal":"Stem Cells","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined cellular phenotype and gene expression readout","pmids":["18323406"],"is_preprint":false},{"year":2011,"finding":"ARID1A and ARID1B are mutually exclusive subunits of the BAF complex and show distinct cell-cycle expression kinetics: ARID1A accumulates in G0 and is absent during mitosis, whereas ARID1B is expressed at comparable levels throughout all cell cycle phases including mitosis, consistent with differential roles in SWI/SNF-mediated corepression (ARID1A) versus coactivation (ARID1B) of cell-cycle genes.","method":"Immunofluorescence, western blotting across cell cycle phases in mouse embryos and cell lines","journal":"Cell and Tissue Research","confidence":"Medium","confidence_rationale":"Tier 3 — direct localization/expression experiments with functional inference; single lab","pmids":["21647563"],"is_preprint":false},{"year":2014,"finding":"ARID1B is mutually exclusive with ARID1A in SWI/SNF (cBAF) complexes; loss of ARID1B in ARID1A-deficient backgrounds destabilizes SWI/SNF and impairs proliferation, establishing a synthetic lethal relationship.","method":"RNAi/shRNA knockdown in cancer cell lines with defined genetic backgrounds, proliferation assays, co-immunoprecipitation to show mutual exclusivity and complex destabilization","journal":"Nature Medicine","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis (synthetic lethality), Co-IP showing complex destabilization, replicated across multiple cell lines","pmids":["24562383"],"is_preprint":false},{"year":2014,"finding":"Both ARID1A and ARID1B are required for non-homologous end joining (NHEJ) repair of DNA double-strand breaks; suppression of either leads to reduced KU70/KU80 accumulation at DSBs, impaired NHEJ activity, and sensitivity to ionizing radiation, cisplatin, and UV. ARID1A, ARID1B, SNF5, and BAF60c are all necessary for immediate recruitment of the SWI/SNF ATPase subunit to DSBs.","method":"Live-cell imaging of DSB repair kinetics, siRNA knockdown, clonogenic survival assays, laser-induced DSB recruitment assays","journal":"Cancer Research","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (live imaging, NHEJ assay, KU recruitment, clonogenic survival) in one study","pmids":["24788099"],"is_preprint":false},{"year":2014,"finding":"ARID1B haploinsufficiency in patient-derived fibroblasts causes delayed cell cycle re-entry (delayed G1-to-S transition) after serum starvation, indicating a direct role for ARID1B in cell cycle control.","method":"Patient-derived fibroblasts with ARID1B deletion and ARID1B knockdown fibroblasts, serum starvation/re-entry assays, flow cytometry","journal":"Orphanet Journal of Rare Diseases","confidence":"Medium","confidence_rationale":"Tier 2 — patient-derived cells plus knockdown, but single lab and single phenotypic readout","pmids":["24674232"],"is_preprint":false},{"year":2015,"finding":"ARID1B represses Wnt/β-catenin signaling: ARID1B associates with β-catenin and represses Wnt/β-catenin-dependent transcription via BRG1. Mutations that delete the BRG1-binding domain of ARID1B abolish β-catenin association and fail to suppress Wnt signaling. Knockdown of ARID1B in neuroblastoma cells promotes neurite outgrowth through β-catenin.","method":"Transcriptome analysis of patient cells, luciferase reporter assays, co-immunoprecipitation of endogenous and exogenous ARID1B with β-catenin, domain-deletion mutants, siRNA knockdown, neurite outgrowth assays","journal":"American Journal of Human Genetics","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including Co-IP, reporter assays, mutagenesis, and patient transcriptome; single lab but rigorous","pmids":["26340334"],"is_preprint":false},{"year":2015,"finding":"ARID1B knockdown in breast cancer cells (MDA-MB-231) delays G1-to-S phase cell cycle transition and decreases cell proliferation.","method":"siRNA knockdown, flow cytometry cell cycle analysis, proliferation assays","journal":"Histopathology","confidence":"Medium","confidence_rationale":"Tier 2 — clean KD with defined cellular phenotype; single lab","pmids":["25817822"],"is_preprint":false},{"year":2016,"finding":"STAT3 represses Arid1b transcription in Schwann cells through histone modification in a BRG1-dependent manner, thereby increasing β-catenin activity and promoting neurofibroma initiation; knockdown of Arid1b rescues neurofibroma formation in Stat3-null SCPs, placing Arid1b downstream of STAT3 and upstream of β-catenin in this pathway.","method":"Insertional mutagenesis screen, mouse genetic models (Stat3 conditional KO, Nf1 KO), in vivo transplantation rescue experiments, ChIP for histone modifications, molecular epistasis","journal":"Cell Reports","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis confirmed by in vivo rescue plus ChIP; multiple orthogonal methods","pmids":["26904939"],"is_preprint":false},{"year":2016,"finding":"ARID1B is required for dendritic arborization and spine morphology of developing cortical and hippocampal pyramidal neurons; ARID1B knockdown suppresses dendritic outgrowth and alters dendritic spine morphology, accompanied by reduced c-Fos and Arc expression. Overexpression of c-Fos and Arc rescues the arborization defects, placing these activity-regulated genes downstream of ARID1B.","method":"In utero electroporation knockdown in mice, confocal imaging of dendritic morphology, electrophysiology, rescue experiments with c-Fos/Arc overexpression","journal":"Journal of Neuroscience","confidence":"High","confidence_rationale":"Tier 2 — in utero KD with specific morphological phenotype and epistatic rescue experiments","pmids":["26937011"],"is_preprint":false},{"year":2017,"finding":"Arid1b haploinsufficiency in mice reduces cortical GABAergic interneuron number by suppressing proliferation of interneuron progenitors in the ganglionic eminence, leading to E/I imbalance in the cortex. Mechanistically, Arid1b haploinsufficiency suppresses H3K9 acetylation overall and specifically reduces H3K9ac at the Pvalb promoter, decreasing parvalbumin transcription.","method":"Arid1b heterozygous knockout mice, immunostaining for interneuron markers, BrdU proliferation assays, ChIP for H3K9ac, quantitative RT-PCR, behavioral testing with GABAA modulator rescue","journal":"Nature Neuroscience","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (ChIP, immunostaining, proliferation, pharmacological rescue) in a single rigorous study","pmids":["29184203"],"is_preprint":false},{"year":2017,"finding":"Arid1b haploinsufficiency leads to IGF1 deficiency with inadequate compensation by GHRH/GH signaling, contributing to growth impairment; GH supplementation corrects growth retardation and muscle weakness in Arid1b heterozygous mice without rescuing behavioral abnormalities.","method":"Arid1b heterozygous knockout mice, hormone measurement, pharmacological GH supplementation with growth and behavior readouts","journal":"eLife","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological rescue experiment with selective phenotypic readout; single lab","pmids":["28695822"],"is_preprint":false},{"year":2018,"finding":"miR-486-3p directly targets the 3'-UTR of ARID1B and represses ARID1B mRNA and protein expression; overexpression of miR-486-3p decreases ARID1B levels while inhibition increases them in SH-SY5Y neuroblastoma cells.","method":"Luciferase 3'-UTR reporter assay, miRNA transfection/inhibitor in SH-SY5Y cells, qRT-PCR and western blot","journal":"Neuroreport","confidence":"Medium","confidence_rationale":"Tier 2 — direct luciferase validation of miRNA-target interaction with functional overexpression/inhibition; single lab","pmids":["30260819"],"is_preprint":false},{"year":2020,"finding":"Dual ARID1A/ARID1B loss causes carcinogenesis through de-differentiation and hyperproliferation; biochemically, loss of ARID1 scaffolding produces residual cBAF subcomplexes that disrupt pBAF function. Re-introduction of either ARID1A or ARID1B in double-mutant endometrial cancer cells induces senescence. 37 of 69 cancer-derived mutations in conserved ARID1 scaffolding domains cause complex disassembly.","method":"Double knockout mouse models (liver, skin), add-back experiments in endometrial cancer cells, biochemical complex analysis, mutagenesis screen of 69 clinical mutations","journal":"Nature Cancer","confidence":"High","confidence_rationale":"Tier 1–2 — reconstitution/add-back, systematic mutagenesis of cancer variants, multiple tissue models, mechanistic biochemistry","pmids":["34386776"],"is_preprint":false},{"year":2020,"finding":"Arid1b deletion in ventral (inhibitory) neural progenitors causes more pronounced reduction in proliferation, altered cell cycle regulation, and increased apoptosis compared to cortical progenitors; Arid1b deficiency decreases nuclear localization of β-catenin in neurons, linking ARID1B to Wnt/β-catenin nuclear signaling in neural progenitors.","method":"Conditional Arid1b knockout mice (ventral vs. cortical progenitors), BrdU/Ki67 proliferation assays, apoptosis assays, β-catenin immunostaining/fractionation, behavioral testing","journal":"Scientific Reports","confidence":"Medium","confidence_rationale":"Tier 2 — conditional KO with specific cellular phenotype and β-catenin localization assay; single lab","pmids":["33594090"],"is_preprint":false},{"year":2020,"finding":"Arid1b haploinsufficiency in PV interneurons causes social and emotional impairments, while deletion in SST interneurons causes stereotypies and learning/memory deficits, demonstrating interneuron-subtype-specific contributions to distinct behavioral phenotypes.","method":"Conditional Arid1b heterozygous knockout mice in PV-Cre or SST-Cre backgrounds, comprehensive behavioral testing","journal":"Scientific Reports","confidence":"Medium","confidence_rationale":"Tier 2 — cell-type-specific conditional KO with defined behavioral phenotypic readouts; single lab","pmids":["32398858"],"is_preprint":false},{"year":2021,"finding":"TNPO1 (importin β) mediates nuclear import of ARID1B; TNPO1 knockdown prevents ARID1B nuclear localization, reduces H3K4me1 and H3K27ac at AP-1 target loci, and inactivates PI3K/AKT signaling. ARID1A-deficient gynecologic cancer cells are selectively sensitive to TNPO1 perturbation.","method":"siRNA knockdown of TNPO1, immunofluorescence/fractionation for ARID1B localization, ChIP for histone marks, ATAC-seq for chromatin accessibility, in vitro and in vivo proliferation assays","journal":"Cancer Letters","confidence":"Medium","confidence_rationale":"Tier 2 — direct nuclear import experiments with chromatin accessibility readout; single lab","pmids":["34044070"],"is_preprint":false},{"year":2021,"finding":"ARID1B-BAF (cBAF with ARID1B) is the lineage-specific BAF configuration active during neuroectoderm specification; at the onset of differentiation, cells switch from ARID1A-BAF to ARID1B-BAF, which attenuates NANOG/SOX2 enhancers and triggers pluripotency exit. Coffin-Siris patient iPSCs fail to perform this ARID1A→ARID1B subunit switch, maintaining persistent NANOG/SOX2 activity that impairs neural crest cell formation.","method":"Patient-derived iPSCs differentiated to cranial neural crest cells, ChIP-seq for ARID1A/ARID1B occupancy, ATAC-seq, RNA-seq, NANOG/SOX2 immunostaining","journal":"Nature Communications","confidence":"High","confidence_rationale":"Tier 1–2 — chromatin occupancy (ChIP-seq), accessibility (ATAC-seq), transcriptomics, and patient cell models with multiple orthogonal methods","pmids":["34753942"],"is_preprint":false},{"year":2021,"finding":"Cytoplasmic mislocalization of ARID1B (caused by NLS mutations) confers a gain-of-oncogenic function: cytoplasmic ARID1B binds c-RAF (RAF1) and PPP1CA, stimulating RAF-ERK signaling and β-catenin transcriptional activity, promoting tumor growth in cell lines and mouse xenografts.","method":"NLS mutant construction, subcellular fractionation, fluorescence microscopy, Co-IP of cytoplasmic ARID1B with RAF1/PPP1CA, mouse xenograft assays, IHC on pancreatic tumor tissue microarray","journal":"Journal of Cell Science","confidence":"High","confidence_rationale":"Tier 2 — Co-IP of specific binding partners, mutagenesis (NLS mutants), in vivo xenograft, and IHC correlation; multiple orthogonal methods","pmids":["33443092"],"is_preprint":false},{"year":2021,"finding":"ARID1B is a molecular suppressor of erythropoiesis under hypoxia: ARID1B knockdown increases GATA1 levels ~3-fold and RBC levels ~100-fold under hypoxia, lowers p53, decreases apoptosis, and alters chromatin accessibility at GATA1/p53 target genes (shown by ATAC-seq), establishing ARID1B as an epigenetic regulator of erythroid gene programs.","method":"iPSC-derived erythroid differentiation model, ARID1B knockdown, ATAC-seq, RT-PCR, flow cytometry for erythroid markers","journal":"Experimental & Molecular Medicine","confidence":"Medium","confidence_rationale":"Tier 2 — ATAC-seq plus KD with quantitative erythroid phenotype; single lab","pmids":["35672450"],"is_preprint":false},{"year":2022,"finding":"ARID1B of the cBAF complex directly interacts with the long non-coding RNA NEAT1 of paraspeckles; this interaction mediates paraspeckle-SWI/SNF binding. ARID1B depletion reduces binding of paraspeckle proteins to chromatin modifiers, transcription factors, and histones, and loss of ARID1B or NEAT1 co-regulates a common set of transcribed and alternatively spliced genes.","method":"Co-immunoprecipitation of ARID1B with NEAT1, RNA pulldown, mass spectrometry, ChIP, RNA-seq and splicing analysis after ARID1B or NEAT1 depletion","journal":"EMBO Reports","confidence":"High","confidence_rationale":"Tier 2 — direct RNA-protein interaction by Co-IP and pulldown, MS interactome, functional transcriptomic readouts; multiple orthogonal methods","pmids":["36354291"],"is_preprint":false},{"year":2022,"finding":"The ARID domain of ARID1B (BAF250b) contains a short β-sheet absent in its paralog ARID1A's ARID domain; NMR chemical shift perturbations identified the DNA-binding interface, and ITC showed moderate affinity binding to DNA with distinct thermodynamic signatures compared to ARID1A, suggesting structural differences influence DNA-binding specificity.","method":"NMR backbone assignment and chemical shift perturbation, ITC, crystal structure comparison, HADDOCK computational docking","journal":"Protein Science","confidence":"High","confidence_rationale":"Tier 1 — NMR structure with functional DNA-binding validation by ITC; multiple biophysical methods","pmids":["35481652"],"is_preprint":false},{"year":2022,"finding":"Early postnatal serotonin modulation with fluoxetine in Arid1b+/- mice prevents adult-stage excitatory synaptic deficits and autistic-like behaviors through transcriptomic changes including normalization of HDAC4/MEF2A-regulated genes (SynGAP1, Arc) and upregulation of FMRP targets.","method":"Arid1b+/- mice, chronic postnatal fluoxetine treatment, electrophysiology, behavioral testing, RNA-seq transcriptome analysis","journal":"Nature Communications","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological rescue with transcriptomic mechanism; single lab","pmids":["36030255"],"is_preprint":false},{"year":2023,"finding":"ARID1B binds the mTOR promoter and negatively regulates mTOR transcription; methionine reduces ARID1B binding at this promoter (via PI3K-dependent reduction of ARID1B protein through proteasomal degradation), thereby relieving ARID1B-mediated repression of mTOR and stimulating milk fat/protein synthesis and proliferation in mammary epithelial cells.","method":"ARID1B knockdown/activation in HC11 cells, mTOR promoter ChIP/binding assays, cycloheximide/MG132/chloroquine inhibitor experiments, proliferation and lipid synthesis assays","journal":"Journal of Nutritional Biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — direct promoter binding shown by ChIP plus degradation mechanism dissected; single lab","pmids":["36681308"],"is_preprint":false},{"year":2024,"finding":"Protein destabilization is the primary mechanism by which pathogenic missense mutations in ARID1B cause Coffin-Siris syndrome, as demonstrated by saturated mutagenesis screens; non-truncating mutations in the EHD2 (BRG1-interacting) and ARID domains cause protein misfolding and formation of cytoplasmic aggresomes (surrounded by vimentin, co-localizing with MTOC), with nuclear aggregates also forming for ARID domain variants, while protein levels are maintained.","method":"Saturated mutagenesis screen, overexpression assays with fluorescent reporters, western blot quantification, immunofluorescence for aggresome markers (vimentin, MTOC), genome-wide transcriptome and methylation analysis","journal":"Nature Structural & Molecular Biology / Human Genetics","confidence":"High","confidence_rationale":"Tier 1 — saturated mutagenesis with multiple orthogonal mechanistic readouts in two independent studies","pmids":["38347147","39028335"],"is_preprint":false},{"year":2024,"finding":"ARID1B controls chromatin accessibility at TCF-like, NFI-like, and ARID-like transcription factor binding regions in SATB2+ callosal projection neurons; ARID1B+/- neural organoids show impaired SATB2+ neuron maturation and reduced chromatin accessibility at these loci, causing transcriptional dysregulation of corpus callosum development genes and impaired long-range axonal projections.","method":"ARID1B+/- neural organoids, ATAC-seq, RNA-seq, in vitro corpus callosum tract model for axonal projection, SATB2 immunostaining","journal":"Cell Stem Cell","confidence":"High","confidence_rationale":"Tier 1–2 — ATAC-seq plus RNA-seq plus functional axon projection assay in patient-derived organoid model; multiple orthogonal methods","pmids":["38718796"],"is_preprint":false},{"year":2024,"finding":"ARID1B loss in the hematopoietic compartment impairs myeloid reconstitution in transplantation experiments and double ARID1A/ARID1B knockout causes acute bone marrow failure. ATAC-seq revealed that >80% of chromatin loci regulated by ARID1B are distinct from those regulated by ARID1A, with ARID1B controlling expression of genes crucial for myelopoiesis.","method":"Hematopoietic-specific conditional Arid1b knockout mice, bone marrow transplantation, ATAC-seq, RNA-seq","journal":"Blood Advances","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with transplantation readout and genome-wide chromatin profiling; well-controlled","pmids":["37611161"],"is_preprint":false},{"year":2024,"finding":"ARID1B maintains mesenchymal stem cell quiescence by suppressing BCL11B expression through direct binding to BCL11B's third intron; loss of ARID1B upregulates BCL11B, which in turn activates non-canonical Activin signaling (via INHBA/activin A and p-ERK), driving MSC proliferation. Reduction of BCL11B or inhibition of non-canonical Activin signaling restores MSC quiescence in Arid1b mutant mice.","method":"scRNA-seq, scATAC-seq of GLI1+ MSC lineage in Arid1b conditional KO mice, ChIP for ARID1B binding at Bcl11b intron, rescue experiments (Bcl11b reduction, Activin pathway inhibition), phospho-ERK immunostaining","journal":"Nature Communications","confidence":"High","confidence_rationale":"Tier 1–2 — direct binding shown by ChIP plus epistatic rescue experiments plus scRNA/scATAC-seq; multiple orthogonal methods","pmids":["38816354"],"is_preprint":false},{"year":2024,"finding":"ARID1B nuclear import is mediated by a KPNA2-KPNB1-RANBP2 cascade; specific residues R1518, H1519, and D1522 on ARID1B mediate interaction with KPNA2/KPNB1. Mutation of these residues attenuates the ARID1B-KPNA2/KPNB1 interaction and prevents ARID1B recruitment to the nuclear pore complex. Pharmacological inhibition of KPNB1 suppresses ARID1B nuclear translocation.","method":"Protein complex purification, mass spectrometry, site-directed mutagenesis of NLS residues, Co-IP, pharmacological KPNB1 inhibition, TNBC mouse xenograft models","journal":"Advanced Science","confidence":"High","confidence_rationale":"Tier 1–2 — MS-identified complex, mutagenesis of interaction residues, pharmacological rescue, in vivo validation","pmids":["40671262"],"is_preprint":false},{"year":2024,"finding":"ARID1B knockdown in lung cancer cell lines impairs DNA damage repair, alters chromatin accessibility, and activates the cGAS-STING pathway, mechanistically linking ARID1B loss to innate immune signaling.","method":"siRNA knockdown, DNA damage assays (γH2AX foci, RAD51 foci), ATAC-seq for chromatin accessibility, cGAS-STING pathway marker analysis","journal":"Journal of Cancer","confidence":"Medium","confidence_rationale":"Tier 2 — KD with multiple functional readouts (DNA repair, chromatin, innate immunity); single lab","pmids":["38577613"],"is_preprint":false},{"year":2024,"finding":"mRNA display identified peptidic ligands that bind ARID1B with nanomolar affinity and high selectivity over ARID1A, engaging two distinct binding pockets; one pocket involves an ARID1B-exclusive cysteine residue that enables covalent targeting, providing first evidence of ARID1B ligandability.","method":"mRNA display peptide selection, biochemical binding assays, biophysical characterization (SPR/ITC), chemical biology pulldowns","journal":"ACS Chemical Biology","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstituted binding with multiple orthogonal biophysical validations and covalent engagement demonstrated","pmids":["38655884"],"is_preprint":false}],"current_model":"ARID1B is the largest DNA-binding subunit of the cBAF (canonical BAF/SWI/SNF) chromatin-remodeling complex, where it is mutually exclusive with its paralog ARID1A; it directly binds BRG1 via its EHD2 domain and DNA via its ARID domain, stabilizes the cBAF complex (loss of both ARID1A and ARID1B fully disassembles it), represses Wnt/β-catenin and mTOR transcription, promotes NHEJ-mediated DNA repair by recruiting the SWI/SNF ATPase to double-strand breaks, regulates interneuron progenitor proliferation and histone H3K9 acetylation at inhibitory neuron genes (Pvalb), controls the ARID1A→ARID1B subunit switch required for pluripotency exit during neural lineage commitment, maintains mesenchymal stem cell quiescence by repressing BCL11B/non-canonical Activin signaling, interacts with the lncRNA NEAT1 to couple paraspeckle function to chromatin regulation, and is imported into the nucleus via a KPNA2-KPNB1-RANBP2 cascade; cytoplasmic mislocalization of ARID1B instead activates RAF-ERK oncogenic signaling, and most pathogenic missense mutations cause protein misfolding and aggresome formation rather than loss of protein level."},"narrative":{"teleology":[{"year":2002,"claim":"Identifying ARID1B as a direct BRG1-binding SWI/SNF subunit established its physical basis for chromatin-remodeling function and defined the EHD2 domain as the interaction surface.","evidence":"Co-immunoprecipitation with domain mapping and endogenous complex detection from mouse brain","pmids":["11988099"],"confidence":"High","gaps":["No genome-wide occupancy data","Functional consequence of EHD1–EHD2 intramolecular interaction unknown","No structural model of the ARID1B–BRG1 interface"]},{"year":2008,"claim":"Demonstrating that biallelic ARID1B loss impairs ES cell self-renewal established that the ARID1B-containing BAF complex is required for maintaining pluripotency, not merely a structural component.","evidence":"Biallelic knockout in mouse ES cells with proliferation and gene expression analysis","pmids":["18323406"],"confidence":"High","gaps":["Downstream gene targets not identified genome-wide","Relationship to ARID1A-containing complexes not addressed"]},{"year":2014,"claim":"Establishing mutual exclusivity with ARID1A and synthetic lethality upon dual loss resolved how the two paralogs partition cBAF function and revealed a therapeutically exploitable dependency in ARID1A-mutant cancers.","evidence":"RNAi in genetically defined cancer cell lines with Co-IP showing complex destabilization across multiple lines","pmids":["24562383"],"confidence":"High","gaps":["Genomic targets uniquely controlled by ARID1B-BAF vs. ARID1A-BAF not defined","Mechanism of complex destabilization not structurally resolved"]},{"year":2014,"claim":"Showing that ARID1B is required for KU70/KU80 recruitment to double-strand breaks and NHEJ efficiency expanded its role beyond transcription to DNA repair, explaining radiation and cisplatin sensitivity upon loss.","evidence":"Live-cell laser-induced DSB recruitment, NHEJ reporter assays, clonogenic survival after siRNA knockdown","pmids":["24788099"],"confidence":"High","gaps":["Direct physical contacts between ARID1B-BAF and NHEJ factors not mapped","Relative contributions of ARID1A vs. ARID1B to repair not quantified"]},{"year":2015,"claim":"Demonstrating that ARID1B associates with β-catenin via BRG1 and represses Wnt-dependent transcription linked the cBAF complex to a major developmental signaling pathway and explained neurite outgrowth phenotypes.","evidence":"Co-IP of ARID1B with β-catenin, luciferase Wnt reporters, domain-deletion mutants, siRNA phenotypes in neuroblastoma","pmids":["26340334"],"confidence":"High","gaps":["Direct vs. indirect β-catenin binding not distinguished","Wnt target gene specificity not mapped genome-wide"]},{"year":2016,"claim":"Placing ARID1B downstream of STAT3 and upstream of β-catenin in neurofibroma initiation demonstrated that ARID1B transcription is itself regulated by oncogenic signaling, creating a feedforward loop.","evidence":"Genetic epistasis with in vivo rescue in Stat3/Nf1 conditional KO mice, ChIP for histone modifications at Arid1b locus","pmids":["26904939"],"confidence":"High","gaps":["Whether STAT3 directly binds the Arid1b promoter not definitively shown","Generalizability beyond Schwann cell lineage untested"]},{"year":2017,"claim":"Arid1b haploinsufficiency reducing cortical interneuron number through impaired progenitor proliferation and decreased H3K9ac at the Pvalb promoter provided the first epigenetic mechanism for ARID1B's role in excitatory/inhibitory balance and autism-like behavior.","evidence":"Arid1b+/- mice with BrdU proliferation, ChIP-H3K9ac, interneuron immunostaining, pharmacological GABAA rescue","pmids":["29184203"],"confidence":"High","gaps":["Whether ARID1B directly binds the Pvalb promoter or acts indirectly not resolved","Genome-wide H3K9ac changes not profiled in interneurons specifically"]},{"year":2020,"claim":"Systematic analysis of dual ARID1A/ARID1B loss showed that residual cBAF subcomplexes poison pBAF function and that 37/69 cancer-derived ARID1 mutations disassemble the complex, unifying oncogenesis mechanisms across tissues.","evidence":"Double-KO mouse models (liver, skin), add-back in endometrial cancer cells, biochemical complex analysis of 69 clinical mutations","pmids":["34386776"],"confidence":"High","gaps":["Structural basis of subcomplexes disrupting pBAF not solved","Whether residual subcomplexes have neomorphic chromatin activities unknown"]},{"year":2021,"claim":"Demonstrating the ARID1A→ARID1B subunit switch during neural crest specification, and its failure in Coffin–Siris patient iPSCs, established that the disease arises from impaired lineage commitment rather than simple proliferative defects.","evidence":"ChIP-seq for ARID1A/ARID1B occupancy, ATAC-seq, RNA-seq in patient iPSC-to-neural-crest differentiation","pmids":["34753942"],"confidence":"High","gaps":["Signal that triggers the subunit switch not identified","Whether switch occurs in non-neural lineages not tested"]},{"year":2021,"claim":"Discovering that cytoplasmic mislocalization of ARID1B activates RAF-ERK signaling via direct c-RAF binding revealed a gain-of-function oncogenic mechanism distinct from nuclear loss-of-function.","evidence":"NLS mutant construction, Co-IP with RAF1/PPP1CA, xenograft assays, pancreatic tumor TMA","pmids":["33443092"],"confidence":"High","gaps":["Stoichiometry and structural basis of cytoplasmic ARID1B–RAF1 complex unknown","Frequency of NLS mutations in patient cohorts not systematically assessed"]},{"year":2022,"claim":"Identification of ARID1B as a direct NEAT1-binding partner coupling paraspeckles to chromatin regulation expanded the functional repertoire of cBAF beyond protein-mediated recruitment to include lncRNA-dependent targeting.","evidence":"Co-IP, RNA pulldown, mass spectrometry interactome, RNA-seq/splicing analysis after ARID1B or NEAT1 depletion","pmids":["36354291"],"confidence":"High","gaps":["RNA-binding domain on ARID1B not mapped","Whether other lncRNAs similarly recruit cBAF not tested"]},{"year":2022,"claim":"NMR and ITC characterization of the ARID domain revealed a unique β-sheet element and distinct DNA-binding thermodynamics compared to ARID1A, providing a structural basis for paralog-specific target recognition.","evidence":"NMR backbone assignment, chemical shift perturbation mapping, ITC, HADDOCK docking","pmids":["35481652"],"confidence":"High","gaps":["No co-crystal structure with DNA","How structural differences translate to genomic locus specificity not demonstrated"]},{"year":2024,"claim":"Saturated mutagenesis showed that most pathogenic Coffin–Siris missense mutations cause protein misfolding and aggresome formation rather than reduced expression, redefining the disease mechanism as a proteostasis defect.","evidence":"Saturated mutagenesis screen, fluorescent reporters, aggresome marker immunofluorescence, genome-wide methylation analysis","pmids":["38347147","39028335"],"confidence":"High","gaps":["Whether aggresomes sequester other BAF subunits not tested","Contribution of aggresome toxicity vs. nuclear depletion to phenotype not dissected"]},{"year":2024,"claim":"Defining ARID1B's chromatin targets in callosal projection neurons (SATB2+) and myeloid progenitors, with >80% non-overlapping with ARID1A targets, established paralog-specific chromatin programs in vivo.","evidence":"ATAC-seq/RNA-seq in ARID1B+/- neural organoids and hematopoietic-specific Arid1b KO mice with transplantation","pmids":["38718796","37611161"],"confidence":"High","gaps":["Direct ARID1B ChIP-seq in these lineages not performed","Mechanism selecting ARID1B vs. ARID1A for distinct loci unknown"]},{"year":2024,"claim":"Mapping the KPNA2-KPNB1-RANBP2 nuclear import pathway for ARID1B and identifying critical NLS residues resolved how ARID1B reaches the nucleus and provided a pharmacologically targetable transport mechanism.","evidence":"MS-based complex identification, site-directed mutagenesis of R1518/H1519/D1522, KPNB1 inhibitor, xenograft models","pmids":["40671262"],"confidence":"High","gaps":["Whether ARID1A uses the same import pathway not determined","Therapeutic window of KPNB1 inhibition not established"]},{"year":2024,"claim":"Identification of ARID1B as a repressor of BCL11B/non-canonical Activin signaling in mesenchymal stem cells established a new lineage context (MSC quiescence) and defined a complete epistatic circuit from chromatin to secreted ligand.","evidence":"scRNA-seq/scATAC-seq of GLI1+ MSCs, ChIP at Bcl11b intron, epistatic rescue with Bcl11b reduction and Activin inhibition","pmids":["38816354"],"confidence":"High","gaps":["Whether this circuit operates in other quiescent stem cell populations unknown","Direct ARID1B binding mechanism at intronic element not structurally resolved"]},{"year":null,"claim":"Key unresolved questions include: what signal triggers the ARID1A-to-ARID1B subunit switch, how paralog-specific genomic targeting is achieved at the structural level, whether aggresome formation contributes to Coffin–Siris pathology through toxic gain-of-function or purely through nuclear depletion, and the full catalog of lncRNAs that recruit ARID1B-cBAF to chromatin.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structure of full-length ARID1B or ARID1B-nucleosome complex","Cis-regulatory logic determining ARID1B vs. ARID1A locus selection unknown","Relative contribution of aggresome toxicity vs. nuclear loss in CSS not tested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[21,25]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[20]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[6,10,23,27]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[3,13,18]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,16,17,28]},{"term_id":"GO:0005694","term_label":"chromosome","supporting_discovery_ids":[10,25]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[18,24]}],"pathway":[{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[0,3,10,17,25,26]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[4,29]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[6,8,18,23,27]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[6,10,17,23,27]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[9,10,14,17,25]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[2,5,7]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[13,18,24]}],"complexes":["cBAF (canonical BAF/SWI/SNF)"],"partners":["SMARCA4","CTNNB1","RAF1","NEAT1","KPNA2","KPNB1","PPP1CA","BCL11B"],"other_free_text":[]},"mechanistic_narrative":"ARID1B is a dedicated, mutually exclusive DNA-binding subunit of the canonical BAF (cBAF) chromatin-remodeling complex that functions as a master epigenetic regulator of cell fate decisions, proliferation, and DNA repair across diverse lineages. It directly binds BRG1/SMARCA4 via its C-terminal EHD2 domain and DNA via its ARID domain (which harbors a unique β-sheet absent in ARID1A), stabilizes cBAF integrity—complete loss of both ARID1A and ARID1B disassembles the complex—and controls chromatin accessibility at lineage-specific loci including those governing pluripotency exit during neural crest specification (attenuating NANOG/SOX2 enhancers), GABAergic interneuron development (promoting H3K9ac at Pvalb), myelopoiesis, mesenchymal stem cell quiescence (repressing BCL11B/non-canonical Activin signaling), and erythropoiesis [PMID:11988099, PMID:34386776, PMID:34753942, PMID:29184203, PMID:37611161, PMID:38816354, PMID:35672450]. ARID1B additionally represses Wnt/β-catenin and mTOR transcriptional programs, promotes NHEJ-mediated DNA double-strand break repair by recruiting SWI/SNF to damage sites, and interacts with the lncRNA NEAT1 to couple paraspeckle function to chromatin regulation [PMID:26340334, PMID:36681308, PMID:24788099, PMID:36354291]. Pathogenic missense mutations in the ARID and EHD2 domains cause protein misfolding and aggresome formation rather than simple loss-of-function, and cytoplasmic mislocalization of ARID1B confers a gain-of-oncogenic function by activating RAF-ERK signaling; Coffin–Siris syndrome arises from ARID1B haploinsufficiency that disrupts the ARID1A-to-ARID1B subunit switch required for neural lineage commitment [PMID:38347147, PMID:33443092, PMID:34753942]."},"prefetch_data":{"uniprot":{"accession":"Q8NFD5","full_name":"AT-rich interactive domain-containing protein 1B","aliases":["BRG1-associated factor 250b","BAF250B","BRG1-binding protein hELD/OSA1","Osa homolog 2","hOsa2","p250R"],"length_aa":2319,"mass_kda":243.9,"function":"Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron-specific chromatin remodeling complex (nBAF complex). During neural development a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth (By similarity). Binds DNA non-specifically (PubMed:14982958, PubMed:15170388)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q8NFD5/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ARID1B","classification":"Not Classified","n_dependent_lines":55,"n_total_lines":1208,"dependency_fraction":0.04552980132450331},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000049618","cell_line_id":"CID001878","localizations":[{"compartment":"nucleoplasm","grade":3}],"interactors":[{"gene":"SMARCE1","stoichiometry":10.0},{"gene":"SMARCB1","stoichiometry":10.0},{"gene":"SMARCA4","stoichiometry":10.0},{"gene":"DPF2","stoichiometry":4.0},{"gene":"SMARCC1","stoichiometry":4.0},{"gene":"SMARCC2","stoichiometry":4.0},{"gene":"SMARCD1","stoichiometry":4.0},{"gene":"SMARCD2","stoichiometry":4.0},{"gene":"ACTB","stoichiometry":0.2},{"gene":"ACTG1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID001878","total_profiled":1310},"omim":[{"mim_id":"615873","title":"HELSMOORTEL-VAN DER AA SYNDROME; HVDAS","url":"https://www.omim.org/entry/615873"},{"mim_id":"615866","title":"INTELLECTUAL DEVELOPMENTAL DISORDER WITH MICROCEPHALY AND WITH OR WITHOUT OCULAR MALFORMATIONS OR HYPOGONADOTROPIC HYPOGONADISM; IDDMOH","url":"https://www.omim.org/entry/615866"},{"mim_id":"614556","title":"AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 1B; ARID1B","url":"https://www.omim.org/entry/614556"},{"mim_id":"611386","title":"ACTIVITY-DEPENDENT NEUROPROTECTOR HOMEOBOX; ADNP","url":"https://www.omim.org/entry/611386"},{"mim_id":"608025","title":"NBAS SUBUNIT OF NRZ TETHERING COMPLEX; NBAS","url":"https://www.omim.org/entry/608025"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Plasma membrane","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/ARID1B"},"hgnc":{"alias_symbol":["KIAA1235","ELD/OSA1","p250R","BAF250b","DAN15","6A3-5","SMARCF2"],"prev_symbol":[]},"alphafold":{"accession":"Q8NFD5","domains":[{"cath_id":"1.10.150.60","chopping":"1046-1146","consensus_level":"high","plddt":84.9295,"start":1046,"end":1146},{"cath_id":"-","chopping":"1615-1698_1806-1819_1903-1909_1920-1978_2000-2051","consensus_level":"medium","plddt":93.2257,"start":1615,"end":2051},{"cath_id":"1.20.1050","chopping":"2124-2236","consensus_level":"medium","plddt":87.8832,"start":2124,"end":2236}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8NFD5","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8NFD5-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8NFD5-F1-predicted_aligned_error_v6.png","plddt_mean":46.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ARID1B","jax_strain_url":"https://www.jax.org/strain/search?query=ARID1B"},"sequence":{"accession":"Q8NFD5","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8NFD5.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8NFD5/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8NFD5"}},"corpus_meta":[{"pmid":"23202128","id":"PMC_23202128","title":"Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma.","date":"2012","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23202128","citation_count":341,"is_preprint":false},{"pmid":"24562383","id":"PMC_24562383","title":"ARID1B is a specific vulnerability in ARID1A-mutant cancers.","date":"2014","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24562383","citation_count":337,"is_preprint":false},{"pmid":"22426309","id":"PMC_22426309","title":"Mutations in SWI/SNF chromatin remodeling complex gene ARID1B cause Coffin-Siris syndrome.","date":"2012","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22426309","citation_count":287,"is_preprint":false},{"pmid":"24788099","id":"PMC_24788099","title":"SWI/SNF factors required for cellular resistance to DNA damage include ARID1A and ARID1B and show interdependent protein stability.","date":"2014","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/24788099","citation_count":156,"is_preprint":false},{"pmid":"29184203","id":"PMC_29184203","title":"Arid1b haploinsufficiency disrupts cortical interneuron development and mouse behavior.","date":"2017","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/29184203","citation_count":142,"is_preprint":false},{"pmid":"18323406","id":"PMC_18323406","title":"BAF250B-associated SWI/SNF chromatin-remodeling complex is required to maintain undifferentiated mouse embryonic stem cells.","date":"2008","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/18323406","citation_count":141,"is_preprint":false},{"pmid":"21801163","id":"PMC_21801163","title":"Corpus callosum abnormalities, intellectual disability, speech impairment, and autism in patients with haploinsufficiency of ARID1B.","date":"2011","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21801163","citation_count":120,"is_preprint":false},{"pmid":"30349098","id":"PMC_30349098","title":"The ARID1B spectrum in 143 patients: from nonsyndromic intellectual disability to Coffin-Siris syndrome.","date":"2018","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30349098","citation_count":104,"is_preprint":false},{"pmid":"24382590","id":"PMC_24382590","title":"Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer.","date":"2014","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/24382590","citation_count":101,"is_preprint":false},{"pmid":"27562491","id":"PMC_27562491","title":"Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas.","date":"2016","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/27562491","citation_count":92,"is_preprint":false},{"pmid":"28695822","id":"PMC_28695822","title":"Arid1b haploinsufficient mice reveal neuropsychiatric phenotypes and reversible causes of growth impairment.","date":"2017","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/28695822","citation_count":90,"is_preprint":false},{"pmid":"26340334","id":"PMC_26340334","title":"Chromatin-Remodeling-Factor ARID1B Represses Wnt/β-Catenin Signaling.","date":"2015","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26340334","citation_count":71,"is_preprint":false},{"pmid":"26937011","id":"PMC_26937011","title":"Essential Roles for ARID1B in Dendritic Arborization and Spine Morphology of Developing Pyramidal Neurons.","date":"2016","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/26937011","citation_count":63,"is_preprint":false},{"pmid":"21647563","id":"PMC_21647563","title":"Dynamics of expression of ARID1A and ARID1B subunits in mouse embryos and in cells during the cell cycle.","date":"2011","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/21647563","citation_count":62,"is_preprint":false},{"pmid":"34512623","id":"PMC_34512623","title":"ARID1A, ARID1B, and ARID2 Mutations Serve as Potential Biomarkers for Immune Checkpoint Blockade in Patients With Non-Small Cell Lung Cancer.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34512623","citation_count":57,"is_preprint":false},{"pmid":"9950359","id":"PMC_9950359","title":"Sex related expressivity of the phenotype in coronal craniosynostosis caused by the recurrent P250R FGFR3 mutation.","date":"1999","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9950359","citation_count":56,"is_preprint":false},{"pmid":"26904939","id":"PMC_26904939","title":"Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/26904939","citation_count":55,"is_preprint":false},{"pmid":"27392123","id":"PMC_27392123","title":"Frequency and outcome of pediatric acute lymphoblastic leukemia with ZNF384 gene rearrangements including a novel translocation resulting in an ARID1B/ZNF384 gene fusion.","date":"2016","source":"Pediatric blood & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/27392123","citation_count":54,"is_preprint":false},{"pmid":"23660946","id":"PMC_23660946","title":"ARID1B, a member of the human SWI/SNF chromatin remodeling complex, exhibits tumour-suppressor activities in pancreatic cancer cell lines.","date":"2013","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/23660946","citation_count":52,"is_preprint":false},{"pmid":"34386776","id":"PMC_34386776","title":"Dual ARID1A/ARID1B loss leads to rapid carcinogenesis and disruptive redistribution of BAF complexes.","date":"2020","source":"Nature cancer","url":"https://pubmed.ncbi.nlm.nih.gov/34386776","citation_count":49,"is_preprint":false},{"pmid":"15915095","id":"PMC_15915095","title":"FGFR3 P250R mutation increases the risk of reoperation in apparent 'nonsyndromic' coronal craniosynostosis.","date":"2005","source":"The Journal of craniofacial surgery","url":"https://pubmed.ncbi.nlm.nih.gov/15915095","citation_count":43,"is_preprint":false},{"pmid":"33686214","id":"PMC_33686214","title":"Neurobiology of ARID1B haploinsufficiency related to neurodevelopmental and psychiatric disorders.","date":"2021","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/33686214","citation_count":38,"is_preprint":false},{"pmid":"11988099","id":"PMC_11988099","title":"Cloning and characterization of hELD/OSA1, a novel BRG1 interacting protein.","date":"2002","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/11988099","citation_count":36,"is_preprint":false},{"pmid":"9279764","id":"PMC_9279764","title":"Phenotypic expression of the fibroblast growth factor receptor 3 (FGFR3) mutation P250R in a large craniosynostosis family.","date":"1997","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9279764","citation_count":35,"is_preprint":false},{"pmid":"25674384","id":"PMC_25674384","title":"ARID1B-mediated disorders: Mutations and possible mechanisms.","date":"2015","source":"Intractable & rare diseases research","url":"https://pubmed.ncbi.nlm.nih.gov/25674384","citation_count":34,"is_preprint":false},{"pmid":"30260819","id":"PMC_30260819","title":"Serum miRNA expression profiling reveals miR-486-3p may play a significant role in the development of autism by targeting ARID1B.","date":"2018","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/30260819","citation_count":34,"is_preprint":false},{"pmid":"28877054","id":"PMC_28877054","title":"Melanotic Translocation Renal Cell Carcinoma With a Novel ARID1B-TFE3 Gene Fusion.","date":"2017","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/28877054","citation_count":33,"is_preprint":false},{"pmid":"31796878","id":"PMC_31796878","title":"Targeting ARID1A-mutant colorectal cancer: depletion of ARID1B increases radiosensitivity and modulates DNA damage response.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31796878","citation_count":30,"is_preprint":false},{"pmid":"24649241","id":"PMC_24649241","title":"Jumonji/Arid1b (Jarid1b) protein modulates human esophageal cancer cell growth.","date":"2013","source":"Molecular and clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/24649241","citation_count":30,"is_preprint":false},{"pmid":"26637902","id":"PMC_26637902","title":"Loss of ARID1A, ARID1B, and ARID2 Expression During Progression of Gastric Cancer.","date":"2015","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/26637902","citation_count":29,"is_preprint":false},{"pmid":"38718796","id":"PMC_38718796","title":"ARID1B controls transcriptional programs of axon projection in an organoid model of the human corpus callosum.","date":"2024","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/38718796","citation_count":28,"is_preprint":false},{"pmid":"34753942","id":"PMC_34753942","title":"Inability to switch from ARID1A-BAF to ARID1B-BAF impairs exit from pluripotency and commitment towards neural crest formation in ARID1B-related neurodevelopmental disorders.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34753942","citation_count":26,"is_preprint":false},{"pmid":"26376624","id":"PMC_26376624","title":"De novo mutations in ARID1B associated with both syndromic and non-syndromic short stature.","date":"2015","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/26376624","citation_count":26,"is_preprint":false},{"pmid":"33748136","id":"PMC_33748136","title":"The Evolutionary Conserved SWI/SNF Subunits ARID1A and ARID1B Are Key Modulators of Pluripotency and Cell-Fate Determination.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/33748136","citation_count":26,"is_preprint":false},{"pmid":"33757588","id":"PMC_33757588","title":"Neuroanatomy and behavior in mice with a haploinsufficiency of AT-rich interactive domain 1B (ARID1B) throughout development.","date":"2021","source":"Molecular autism","url":"https://pubmed.ncbi.nlm.nih.gov/33757588","citation_count":25,"is_preprint":false},{"pmid":"36354291","id":"PMC_36354291","title":"Paraspeckles interact with SWI/SNF subunit ARID1B to regulate transcription and splicing.","date":"2022","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/36354291","citation_count":24,"is_preprint":false},{"pmid":"32398858","id":"PMC_32398858","title":"Arid1b haploinsufficiency in parvalbumin- or somatostatin-expressing interneurons leads to distinct ASD-like and ID-like behavior.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32398858","citation_count":24,"is_preprint":false},{"pmid":"30149092","id":"PMC_30149092","title":"The role of ARID1B, a BAF chromatin remodeling complex subunit, in neural development and behavior.","date":"2018","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/30149092","citation_count":23,"is_preprint":false},{"pmid":"29890703","id":"PMC_29890703","title":"ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma.","date":"2018","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29890703","citation_count":23,"is_preprint":false},{"pmid":"33262327","id":"PMC_33262327","title":"Autism-associated miR-873 regulates ARID1B, SHANK3 and NRXN2 involved in neurodevelopment.","date":"2020","source":"Translational psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/33262327","citation_count":22,"is_preprint":false},{"pmid":"31981384","id":"PMC_31981384","title":"De Novo ARID1B mutations cause growth delay associated with aberrant Wnt/β-catenin signaling.","date":"2020","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/31981384","citation_count":21,"is_preprint":false},{"pmid":"28521285","id":"PMC_28521285","title":"ARID1B alterations identify aggressive tumors in neuroblastoma.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28521285","citation_count":21,"is_preprint":false},{"pmid":"32910019","id":"PMC_32910019","title":"BRG1, INI1, and ARID1B Deficiency in Endometrial Carcinoma: A Clinicopathologic and Immunohistochemical Analysis of a Large Series From a Single Institution.","date":"2020","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/32910019","citation_count":20,"is_preprint":false},{"pmid":"11424131","id":"PMC_11424131","title":"Premature calvarial synostosis and epidermal hyperplasia (Beare-Stevenson syndrome-like anomalies) resulting from a P250R missense mutation in the gene encoding fibroblast growth factor receptor 3.","date":"2001","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11424131","citation_count":20,"is_preprint":false},{"pmid":"25817822","id":"PMC_25817822","title":"Clinicopathological significance of ARID1B in breast invasive ductal carcinoma.","date":"2015","source":"Histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/25817822","citation_count":19,"is_preprint":false},{"pmid":"24569609","id":"PMC_24569609","title":"Coffin-Siris Syndrome with obesity, macrocephaly, hepatomegaly and hyperinsulinism caused by a mutation in the ARID1B gene.","date":"2014","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/24569609","citation_count":19,"is_preprint":false},{"pmid":"29151933","id":"PMC_29151933","title":"Expression of ARID1B Is Associated With Poor Outcomes and Predicts the Benefit from Adjuvant Chemotherapy in Bladder Urothelial Carcinoma.","date":"2017","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/29151933","citation_count":18,"is_preprint":false},{"pmid":"26754677","id":"PMC_26754677","title":"Interstitial 6q25 microdeletion syndrome: ARID1B is the key gene.","date":"2016","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/26754677","citation_count":18,"is_preprint":false},{"pmid":"33683826","id":"PMC_33683826","title":"ARID1B/SUB1-activated lncRNA HOXA-AS2 drives the malignant behaviour of hepatoblastoma through regulation of HOXA3.","date":"2021","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33683826","citation_count":18,"is_preprint":false},{"pmid":"24674232","id":"PMC_24674232","title":"Expanding the phenotypic spectrum of ARID1B-mediated disorders and identification of altered cell-cycle dynamics due to ARID1B haploinsufficiency.","date":"2014","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/24674232","citation_count":18,"is_preprint":false},{"pmid":"33594090","id":"PMC_33594090","title":"Differential roles of ARID1B in excitatory and inhibitory neural progenitors in the developing cortex.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33594090","citation_count":17,"is_preprint":false},{"pmid":"27511161","id":"PMC_27511161","title":"Hirschsprung disease as a yet undescribed phenotype in a patient with ARID1B mutation.","date":"2016","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/27511161","citation_count":17,"is_preprint":false},{"pmid":"27570168","id":"PMC_27570168","title":"A novel familial autosomal dominant mutation in ARID1B causing neurodevelopmental delays, short stature, and dysmorphic features.","date":"2016","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/27570168","citation_count":16,"is_preprint":false},{"pmid":"33432679","id":"PMC_33432679","title":"Loss of ARID1B and SMARCB1 expression are specific for the diagnosis of dedifferentiated/undifferentiated carcinoma in tumours of the upper gynaecological tract and cervix.","date":"2021","source":"Histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/33432679","citation_count":15,"is_preprint":false},{"pmid":"26395437","id":"PMC_26395437","title":"Gonadal mosaicism in ARID1B gene causes intellectual disability and dysmorphic features in three siblings.","date":"2015","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/26395437","citation_count":14,"is_preprint":false},{"pmid":"25250687","id":"PMC_25250687","title":"Disruption of the ARID1B and ADAMTS6 loci due to a t(5;6)(q12.3;q25.3) in a patient with developmental delay.","date":"2014","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/25250687","citation_count":13,"is_preprint":false},{"pmid":"35672450","id":"PMC_35672450","title":"ARID1B, a molecular suppressor of erythropoiesis, is essential for the prevention of Monge's disease.","date":"2022","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35672450","citation_count":13,"is_preprint":false},{"pmid":"38577613","id":"PMC_38577613","title":"ARID1B Deficiency Leads to Impaired DNA Damage Response and Activated cGAS-STING Pathway in Non-Small Cell Lung Cancer.","date":"2024","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/38577613","citation_count":13,"is_preprint":false},{"pmid":"36030255","id":"PMC_36030255","title":"Early postnatal serotonin modulation prevents adult-stage deficits in Arid1b-deficient mice through synaptic transcriptional reprogramming.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36030255","citation_count":12,"is_preprint":false},{"pmid":"27672547","id":"PMC_27672547","title":"Coffin-Siris syndrome with café-au-lait spots, obesity and hyperinsulinism caused by a mutation in the ARID1B gene.","date":"2016","source":"Intractable & rare diseases research","url":"https://pubmed.ncbi.nlm.nih.gov/27672547","citation_count":12,"is_preprint":false},{"pmid":"34044070","id":"PMC_34044070","title":"TNPO1-mediated nuclear import of ARID1B promotes tumor growth in ARID1A-deficient gynecologic cancer.","date":"2021","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/34044070","citation_count":11,"is_preprint":false},{"pmid":"34440449","id":"PMC_34440449","title":"A Case Series of Familial ARID1B Variants Illustrating Variable Expression and Suggestions to Update the ACMG Criteria.","date":"2021","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/34440449","citation_count":11,"is_preprint":false},{"pmid":"33443092","id":"PMC_33443092","title":"Aberrant cytoplasmic localization of ARID1B activates ERK signaling and promotes oncogenesis.","date":"2021","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/33443092","citation_count":10,"is_preprint":false},{"pmid":"39536425","id":"PMC_39536425","title":"Mutations of ARID1B, PIK3C2B, KMT2B, and FAT1 genes influence clinical outcome in newly diagnosed myeloma.","date":"2024","source":"Cancer genetics","url":"https://pubmed.ncbi.nlm.nih.gov/39536425","citation_count":9,"is_preprint":false},{"pmid":"31628733","id":"PMC_31628733","title":"De novo splice site variant of ARID1B associated with pathogenesis of Coffin-Siris syndrome.","date":"2019","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31628733","citation_count":9,"is_preprint":false},{"pmid":"17103449","id":"PMC_17103449","title":"Sudden infant death in a patient with FGFR3 P250R mutation.","date":"2006","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/17103449","citation_count":9,"is_preprint":false},{"pmid":"36681308","id":"PMC_36681308","title":"ARID1B blocks methionine-stimulated mTOR activation to inhibit milk fat and protein synthesis in and proliferation of mouse mammary epithelial cells.","date":"2023","source":"The Journal of nutritional biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36681308","citation_count":9,"is_preprint":false},{"pmid":"38347147","id":"PMC_38347147","title":"Protein destabilization underlies pathogenic missense mutations in ARID1B.","date":"2024","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/38347147","citation_count":8,"is_preprint":false},{"pmid":"31421289","id":"PMC_31421289","title":"Striking phenotypic overlap between Nicolaides-Baraitser and Coffin-Siris syndromes in monozygotic twins with ARID1B intragenic deletion.","date":"2019","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31421289","citation_count":7,"is_preprint":false},{"pmid":"28691782","id":"PMC_28691782","title":"A novel microduplication of ARID1B: Clinical, genetic, and proteomic findings.","date":"2017","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/28691782","citation_count":7,"is_preprint":false},{"pmid":"38816354","id":"PMC_38816354","title":"ARID1B maintains mesenchymal stem cell quiescence via inhibition of BCL11B-mediated non-canonical Activin signaling.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38816354","citation_count":6,"is_preprint":false},{"pmid":"35481652","id":"PMC_35481652","title":"Structure and DNA binding analysis of AT-rich interaction domain present in human BAF-B specific subunit BAF250b.","date":"2022","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/35481652","citation_count":6,"is_preprint":false},{"pmid":"35879281","id":"PMC_35879281","title":"A novel nonsense variant in ARID1B causing simultaneous RNA decay and exon skipping is associated with Coffin-Siris syndrome.","date":"2022","source":"Human genome variation","url":"https://pubmed.ncbi.nlm.nih.gov/35879281","citation_count":6,"is_preprint":false},{"pmid":"33949667","id":"PMC_33949667","title":"Downregulation of ARID1B, a tumor suppressor in the WNT subgroup medulloblastoma, activates multiple oncogenic signaling pathways.","date":"2021","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33949667","citation_count":6,"is_preprint":false},{"pmid":"37287661","id":"PMC_37287661","title":"Pleiotropic effects of a high confidence Autism Spectrum Disorder gene, arid1b, on zebrafish sleep.","date":"2023","source":"Neurobiology of sleep and circadian rhythms","url":"https://pubmed.ncbi.nlm.nih.gov/37287661","citation_count":6,"is_preprint":false},{"pmid":"37387408","id":"PMC_37387408","title":"Acute myeloid leukemia with NUP98::RARG resembling acute promyelocytic leukemia accompanying ARID1B gene mutation.","date":"2023","source":"Hematology (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/37387408","citation_count":5,"is_preprint":false},{"pmid":"28415691","id":"PMC_28415691","title":"A potentially functional variant of ARID1B interacts with physical activity in association with risk of hepatocellular carcinoma.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28415691","citation_count":5,"is_preprint":false},{"pmid":"39355979","id":"PMC_39355979","title":"Microduplications of ARID1A and ARID1B cause a novel clinical and epigenetic distinct BAFopathy.","date":"2024","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/39355979","citation_count":4,"is_preprint":false},{"pmid":"34730517","id":"PMC_34730517","title":"Epilepsy features in ARID1B-related Coffin-Siris syndrome.","date":"2021","source":"Epileptic disorders : international epilepsy journal with videotape","url":"https://pubmed.ncbi.nlm.nih.gov/34730517","citation_count":4,"is_preprint":false},{"pmid":"37611161","id":"PMC_37611161","title":"Dissecting the role of SWI/SNF component ARID1B in steady-state hematopoiesis.","date":"2023","source":"Blood advances","url":"https://pubmed.ncbi.nlm.nih.gov/37611161","citation_count":4,"is_preprint":false},{"pmid":"36313455","id":"PMC_36313455","title":"Aberrantly hypermethylated ARID1B is a novel biomarker and potential therapeutic target of colon adenocarcinoma.","date":"2022","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/36313455","citation_count":4,"is_preprint":false},{"pmid":"39028335","id":"PMC_39028335","title":"The missing link: ARID1B non-truncating variants causing Coffin-Siris syndrome due to protein aggregation.","date":"2024","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/39028335","citation_count":4,"is_preprint":false},{"pmid":"37654076","id":"PMC_37654076","title":"Integration of EpiSign, facial phenotyping, and likelihood ratio interpretation of clinical abnormalities in the re-classification of an ARID1B missense variant.","date":"2023","source":"American journal of medical genetics. Part C, Seminars in medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37654076","citation_count":4,"is_preprint":false},{"pmid":"32339967","id":"PMC_32339967","title":"Coffin-Siris Syndrome-1: Report of five cases from Asian populations with truncating mutations in the ARID1B gene.","date":"2020","source":"Journal of the neurological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32339967","citation_count":4,"is_preprint":false},{"pmid":"32161024","id":"PMC_32161024","title":"First Korean Case of Coffin-Siris Syndrome with a Novel Frameshift ARID1B Mutation.","date":"2020","source":"Annals of clinical and laboratory science","url":"https://pubmed.ncbi.nlm.nih.gov/32161024","citation_count":4,"is_preprint":false},{"pmid":"32618029","id":"PMC_32618029","title":"Coffin-Siris syndrome with bilateral macular dysplasia caused by a novel exonic deletion in ARID1B.","date":"2020","source":"Congenital anomalies","url":"https://pubmed.ncbi.nlm.nih.gov/32618029","citation_count":4,"is_preprint":false},{"pmid":"36843546","id":"PMC_36843546","title":"Dedifferentiated Ovarian Carcinoma with ARID1A and ARID1B Mutations: A Clinicopathological Report and Literature Review.","date":"2023","source":"International journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/36843546","citation_count":3,"is_preprint":false},{"pmid":"37556934","id":"PMC_37556934","title":"Establishment and validation of preclinical models of SMARCA4-inactivated and ARID1A/ARID1B co-inactivated dedifferentiated endometrial carcinoma.","date":"2023","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/37556934","citation_count":3,"is_preprint":false},{"pmid":"36352633","id":"PMC_36352633","title":"Three Novel ARID1B Variations in Coffin-Siris Syndrome Patients.","date":"2022","source":"Neurology India","url":"https://pubmed.ncbi.nlm.nih.gov/36352633","citation_count":3,"is_preprint":false},{"pmid":"32682288","id":"PMC_32682288","title":"CRISPR/Cas9 mediated generation of human ARID1B heterozygous knockout hESC lines to model Coffin-Siris syndrome.","date":"2020","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/32682288","citation_count":3,"is_preprint":false},{"pmid":"33936271","id":"PMC_33936271","title":"Novel ARID1B variant inherited from somatogonadal mosaic mother in siblings with Coffin-Siris syndrome 1.","date":"2021","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33936271","citation_count":3,"is_preprint":false},{"pmid":"38655884","id":"PMC_38655884","title":"mRNA Display Identifies Potent, Paralog-Selective Peptidic Ligands for ARID1B.","date":"2024","source":"ACS chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/38655884","citation_count":2,"is_preprint":false},{"pmid":"37686505","id":"PMC_37686505","title":"ARID1B Immunohistochemistry Is an Important Test for the Diagnosis of Dedifferentiated and Undifferentiated Gynecologic Malignancies.","date":"2023","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/37686505","citation_count":2,"is_preprint":false},{"pmid":"38790056","id":"PMC_38790056","title":"De novo variation in ARID1B gene causes Coffin-Siris syndrome 1 in a Chinese family with excessive early-onset high myopia.","date":"2024","source":"BMC medical genomics","url":"https://pubmed.ncbi.nlm.nih.gov/38790056","citation_count":2,"is_preprint":false},{"pmid":"36588753","id":"PMC_36588753","title":"Growth Hormone Deficiency due to p.(Gln467Argfs*64) Mutation in the ARID1B Gene in a Girl with Coffin-Siris Syndrome.","date":"2022","source":"Molecular syndromology","url":"https://pubmed.ncbi.nlm.nih.gov/36588753","citation_count":2,"is_preprint":false},{"pmid":"39446840","id":"PMC_39446840","title":"The SWI/SNF subunit ARID1B is important for regenerative ability of hematopoietic stem cells in normal hematopoiesis.","date":"2024","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/39446840","citation_count":2,"is_preprint":false},{"pmid":"34620277","id":"PMC_34620277","title":"The molecular mechanism of the transcriptional activator SWI regulating gene ARID1B affecting swallowing dysfunction after stroke in rats.","date":"2021","source":"Die Pharmazie","url":"https://pubmed.ncbi.nlm.nih.gov/34620277","citation_count":2,"is_preprint":false},{"pmid":"40671262","id":"PMC_40671262","title":"Disruption of ARID1B Recruitment to the Nuclear Pore Complex as a New Anticancer Therapeutic Strategy.","date":"2025","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/40671262","citation_count":1,"is_preprint":false},{"pmid":"11197897","id":"PMC_11197897","title":"[A case of bilateral coronal craniosynostosis with the P250R mutation in FGFR3 gene].","date":"2001","source":"No to hattatsu = Brain and development","url":"https://pubmed.ncbi.nlm.nih.gov/11197897","citation_count":1,"is_preprint":false},{"pmid":"35315036","id":"PMC_35315036","title":"[Analysis of ARID1B gene variants in two Chinese pedigrees with Coffin-Siris syndrome].","date":"2022","source":"Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35315036","citation_count":1,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47507,"output_tokens":7829,"usd":0.129978},"stage2":{"model":"claude-opus-4-6","input_tokens":11601,"output_tokens":4222,"usd":0.245333},"total_usd":0.375311,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"ARID1B (hELD/OSA1) directly binds BRG1 (SMARCA4) through its C-terminal EHD2 domain, and is incorporated into endogenous SWI/SNF complexes; the EHD1 and EHD2 domains can also interact with each other.\",\n      \"method\": \"Biochemical cloning, co-immunoprecipitation, domain mapping, detection of endogenous complex from mouse brain\",\n      \"journal\": \"The Biochemical Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP with domain-mapping mutagenesis, endogenous complex detected\",\n      \"pmids\": [\"11988099\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"BAF250B (ARID1B)-associated SWI/SNF complex is required for mouse embryonic stem cell self-renewal and normal proliferation; biallelic inactivation of BAF250B reduces pluripotency gene expression and causes aberrant cell cycle.\",\n      \"method\": \"Biallelic knockout of BAF250B in mouse ES cells, colony/proliferation assays, gene expression analysis\",\n      \"journal\": \"Stem Cells\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular phenotype and gene expression readout\",\n      \"pmids\": [\"18323406\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ARID1A and ARID1B are mutually exclusive subunits of the BAF complex and show distinct cell-cycle expression kinetics: ARID1A accumulates in G0 and is absent during mitosis, whereas ARID1B is expressed at comparable levels throughout all cell cycle phases including mitosis, consistent with differential roles in SWI/SNF-mediated corepression (ARID1A) versus coactivation (ARID1B) of cell-cycle genes.\",\n      \"method\": \"Immunofluorescence, western blotting across cell cycle phases in mouse embryos and cell lines\",\n      \"journal\": \"Cell and Tissue Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — direct localization/expression experiments with functional inference; single lab\",\n      \"pmids\": [\"21647563\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ARID1B is mutually exclusive with ARID1A in SWI/SNF (cBAF) complexes; loss of ARID1B in ARID1A-deficient backgrounds destabilizes SWI/SNF and impairs proliferation, establishing a synthetic lethal relationship.\",\n      \"method\": \"RNAi/shRNA knockdown in cancer cell lines with defined genetic backgrounds, proliferation assays, co-immunoprecipitation to show mutual exclusivity and complex destabilization\",\n      \"journal\": \"Nature Medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis (synthetic lethality), Co-IP showing complex destabilization, replicated across multiple cell lines\",\n      \"pmids\": [\"24562383\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Both ARID1A and ARID1B are required for non-homologous end joining (NHEJ) repair of DNA double-strand breaks; suppression of either leads to reduced KU70/KU80 accumulation at DSBs, impaired NHEJ activity, and sensitivity to ionizing radiation, cisplatin, and UV. ARID1A, ARID1B, SNF5, and BAF60c are all necessary for immediate recruitment of the SWI/SNF ATPase subunit to DSBs.\",\n      \"method\": \"Live-cell imaging of DSB repair kinetics, siRNA knockdown, clonogenic survival assays, laser-induced DSB recruitment assays\",\n      \"journal\": \"Cancer Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (live imaging, NHEJ assay, KU recruitment, clonogenic survival) in one study\",\n      \"pmids\": [\"24788099\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ARID1B haploinsufficiency in patient-derived fibroblasts causes delayed cell cycle re-entry (delayed G1-to-S transition) after serum starvation, indicating a direct role for ARID1B in cell cycle control.\",\n      \"method\": \"Patient-derived fibroblasts with ARID1B deletion and ARID1B knockdown fibroblasts, serum starvation/re-entry assays, flow cytometry\",\n      \"journal\": \"Orphanet Journal of Rare Diseases\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — patient-derived cells plus knockdown, but single lab and single phenotypic readout\",\n      \"pmids\": [\"24674232\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"ARID1B represses Wnt/β-catenin signaling: ARID1B associates with β-catenin and represses Wnt/β-catenin-dependent transcription via BRG1. Mutations that delete the BRG1-binding domain of ARID1B abolish β-catenin association and fail to suppress Wnt signaling. Knockdown of ARID1B in neuroblastoma cells promotes neurite outgrowth through β-catenin.\",\n      \"method\": \"Transcriptome analysis of patient cells, luciferase reporter assays, co-immunoprecipitation of endogenous and exogenous ARID1B with β-catenin, domain-deletion mutants, siRNA knockdown, neurite outgrowth assays\",\n      \"journal\": \"American Journal of Human Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including Co-IP, reporter assays, mutagenesis, and patient transcriptome; single lab but rigorous\",\n      \"pmids\": [\"26340334\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"ARID1B knockdown in breast cancer cells (MDA-MB-231) delays G1-to-S phase cell cycle transition and decreases cell proliferation.\",\n      \"method\": \"siRNA knockdown, flow cytometry cell cycle analysis, proliferation assays\",\n      \"journal\": \"Histopathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KD with defined cellular phenotype; single lab\",\n      \"pmids\": [\"25817822\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"STAT3 represses Arid1b transcription in Schwann cells through histone modification in a BRG1-dependent manner, thereby increasing β-catenin activity and promoting neurofibroma initiation; knockdown of Arid1b rescues neurofibroma formation in Stat3-null SCPs, placing Arid1b downstream of STAT3 and upstream of β-catenin in this pathway.\",\n      \"method\": \"Insertional mutagenesis screen, mouse genetic models (Stat3 conditional KO, Nf1 KO), in vivo transplantation rescue experiments, ChIP for histone modifications, molecular epistasis\",\n      \"journal\": \"Cell Reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis confirmed by in vivo rescue plus ChIP; multiple orthogonal methods\",\n      \"pmids\": [\"26904939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"ARID1B is required for dendritic arborization and spine morphology of developing cortical and hippocampal pyramidal neurons; ARID1B knockdown suppresses dendritic outgrowth and alters dendritic spine morphology, accompanied by reduced c-Fos and Arc expression. Overexpression of c-Fos and Arc rescues the arborization defects, placing these activity-regulated genes downstream of ARID1B.\",\n      \"method\": \"In utero electroporation knockdown in mice, confocal imaging of dendritic morphology, electrophysiology, rescue experiments with c-Fos/Arc overexpression\",\n      \"journal\": \"Journal of Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in utero KD with specific morphological phenotype and epistatic rescue experiments\",\n      \"pmids\": [\"26937011\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Arid1b haploinsufficiency in mice reduces cortical GABAergic interneuron number by suppressing proliferation of interneuron progenitors in the ganglionic eminence, leading to E/I imbalance in the cortex. Mechanistically, Arid1b haploinsufficiency suppresses H3K9 acetylation overall and specifically reduces H3K9ac at the Pvalb promoter, decreasing parvalbumin transcription.\",\n      \"method\": \"Arid1b heterozygous knockout mice, immunostaining for interneuron markers, BrdU proliferation assays, ChIP for H3K9ac, quantitative RT-PCR, behavioral testing with GABAA modulator rescue\",\n      \"journal\": \"Nature Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (ChIP, immunostaining, proliferation, pharmacological rescue) in a single rigorous study\",\n      \"pmids\": [\"29184203\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Arid1b haploinsufficiency leads to IGF1 deficiency with inadequate compensation by GHRH/GH signaling, contributing to growth impairment; GH supplementation corrects growth retardation and muscle weakness in Arid1b heterozygous mice without rescuing behavioral abnormalities.\",\n      \"method\": \"Arid1b heterozygous knockout mice, hormone measurement, pharmacological GH supplementation with growth and behavior readouts\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological rescue experiment with selective phenotypic readout; single lab\",\n      \"pmids\": [\"28695822\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"miR-486-3p directly targets the 3'-UTR of ARID1B and represses ARID1B mRNA and protein expression; overexpression of miR-486-3p decreases ARID1B levels while inhibition increases them in SH-SY5Y neuroblastoma cells.\",\n      \"method\": \"Luciferase 3'-UTR reporter assay, miRNA transfection/inhibitor in SH-SY5Y cells, qRT-PCR and western blot\",\n      \"journal\": \"Neuroreport\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct luciferase validation of miRNA-target interaction with functional overexpression/inhibition; single lab\",\n      \"pmids\": [\"30260819\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Dual ARID1A/ARID1B loss causes carcinogenesis through de-differentiation and hyperproliferation; biochemically, loss of ARID1 scaffolding produces residual cBAF subcomplexes that disrupt pBAF function. Re-introduction of either ARID1A or ARID1B in double-mutant endometrial cancer cells induces senescence. 37 of 69 cancer-derived mutations in conserved ARID1 scaffolding domains cause complex disassembly.\",\n      \"method\": \"Double knockout mouse models (liver, skin), add-back experiments in endometrial cancer cells, biochemical complex analysis, mutagenesis screen of 69 clinical mutations\",\n      \"journal\": \"Nature Cancer\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — reconstitution/add-back, systematic mutagenesis of cancer variants, multiple tissue models, mechanistic biochemistry\",\n      \"pmids\": [\"34386776\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Arid1b deletion in ventral (inhibitory) neural progenitors causes more pronounced reduction in proliferation, altered cell cycle regulation, and increased apoptosis compared to cortical progenitors; Arid1b deficiency decreases nuclear localization of β-catenin in neurons, linking ARID1B to Wnt/β-catenin nuclear signaling in neural progenitors.\",\n      \"method\": \"Conditional Arid1b knockout mice (ventral vs. cortical progenitors), BrdU/Ki67 proliferation assays, apoptosis assays, β-catenin immunostaining/fractionation, behavioral testing\",\n      \"journal\": \"Scientific Reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with specific cellular phenotype and β-catenin localization assay; single lab\",\n      \"pmids\": [\"33594090\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Arid1b haploinsufficiency in PV interneurons causes social and emotional impairments, while deletion in SST interneurons causes stereotypies and learning/memory deficits, demonstrating interneuron-subtype-specific contributions to distinct behavioral phenotypes.\",\n      \"method\": \"Conditional Arid1b heterozygous knockout mice in PV-Cre or SST-Cre backgrounds, comprehensive behavioral testing\",\n      \"journal\": \"Scientific Reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific conditional KO with defined behavioral phenotypic readouts; single lab\",\n      \"pmids\": [\"32398858\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TNPO1 (importin β) mediates nuclear import of ARID1B; TNPO1 knockdown prevents ARID1B nuclear localization, reduces H3K4me1 and H3K27ac at AP-1 target loci, and inactivates PI3K/AKT signaling. ARID1A-deficient gynecologic cancer cells are selectively sensitive to TNPO1 perturbation.\",\n      \"method\": \"siRNA knockdown of TNPO1, immunofluorescence/fractionation for ARID1B localization, ChIP for histone marks, ATAC-seq for chromatin accessibility, in vitro and in vivo proliferation assays\",\n      \"journal\": \"Cancer Letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct nuclear import experiments with chromatin accessibility readout; single lab\",\n      \"pmids\": [\"34044070\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ARID1B-BAF (cBAF with ARID1B) is the lineage-specific BAF configuration active during neuroectoderm specification; at the onset of differentiation, cells switch from ARID1A-BAF to ARID1B-BAF, which attenuates NANOG/SOX2 enhancers and triggers pluripotency exit. Coffin-Siris patient iPSCs fail to perform this ARID1A→ARID1B subunit switch, maintaining persistent NANOG/SOX2 activity that impairs neural crest cell formation.\",\n      \"method\": \"Patient-derived iPSCs differentiated to cranial neural crest cells, ChIP-seq for ARID1A/ARID1B occupancy, ATAC-seq, RNA-seq, NANOG/SOX2 immunostaining\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — chromatin occupancy (ChIP-seq), accessibility (ATAC-seq), transcriptomics, and patient cell models with multiple orthogonal methods\",\n      \"pmids\": [\"34753942\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Cytoplasmic mislocalization of ARID1B (caused by NLS mutations) confers a gain-of-oncogenic function: cytoplasmic ARID1B binds c-RAF (RAF1) and PPP1CA, stimulating RAF-ERK signaling and β-catenin transcriptional activity, promoting tumor growth in cell lines and mouse xenografts.\",\n      \"method\": \"NLS mutant construction, subcellular fractionation, fluorescence microscopy, Co-IP of cytoplasmic ARID1B with RAF1/PPP1CA, mouse xenograft assays, IHC on pancreatic tumor tissue microarray\",\n      \"journal\": \"Journal of Cell Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP of specific binding partners, mutagenesis (NLS mutants), in vivo xenograft, and IHC correlation; multiple orthogonal methods\",\n      \"pmids\": [\"33443092\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ARID1B is a molecular suppressor of erythropoiesis under hypoxia: ARID1B knockdown increases GATA1 levels ~3-fold and RBC levels ~100-fold under hypoxia, lowers p53, decreases apoptosis, and alters chromatin accessibility at GATA1/p53 target genes (shown by ATAC-seq), establishing ARID1B as an epigenetic regulator of erythroid gene programs.\",\n      \"method\": \"iPSC-derived erythroid differentiation model, ARID1B knockdown, ATAC-seq, RT-PCR, flow cytometry for erythroid markers\",\n      \"journal\": \"Experimental & Molecular Medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ATAC-seq plus KD with quantitative erythroid phenotype; single lab\",\n      \"pmids\": [\"35672450\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"ARID1B of the cBAF complex directly interacts with the long non-coding RNA NEAT1 of paraspeckles; this interaction mediates paraspeckle-SWI/SNF binding. ARID1B depletion reduces binding of paraspeckle proteins to chromatin modifiers, transcription factors, and histones, and loss of ARID1B or NEAT1 co-regulates a common set of transcribed and alternatively spliced genes.\",\n      \"method\": \"Co-immunoprecipitation of ARID1B with NEAT1, RNA pulldown, mass spectrometry, ChIP, RNA-seq and splicing analysis after ARID1B or NEAT1 depletion\",\n      \"journal\": \"EMBO Reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct RNA-protein interaction by Co-IP and pulldown, MS interactome, functional transcriptomic readouts; multiple orthogonal methods\",\n      \"pmids\": [\"36354291\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The ARID domain of ARID1B (BAF250b) contains a short β-sheet absent in its paralog ARID1A's ARID domain; NMR chemical shift perturbations identified the DNA-binding interface, and ITC showed moderate affinity binding to DNA with distinct thermodynamic signatures compared to ARID1A, suggesting structural differences influence DNA-binding specificity.\",\n      \"method\": \"NMR backbone assignment and chemical shift perturbation, ITC, crystal structure comparison, HADDOCK computational docking\",\n      \"journal\": \"Protein Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structure with functional DNA-binding validation by ITC; multiple biophysical methods\",\n      \"pmids\": [\"35481652\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Early postnatal serotonin modulation with fluoxetine in Arid1b+/- mice prevents adult-stage excitatory synaptic deficits and autistic-like behaviors through transcriptomic changes including normalization of HDAC4/MEF2A-regulated genes (SynGAP1, Arc) and upregulation of FMRP targets.\",\n      \"method\": \"Arid1b+/- mice, chronic postnatal fluoxetine treatment, electrophysiology, behavioral testing, RNA-seq transcriptome analysis\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological rescue with transcriptomic mechanism; single lab\",\n      \"pmids\": [\"36030255\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ARID1B binds the mTOR promoter and negatively regulates mTOR transcription; methionine reduces ARID1B binding at this promoter (via PI3K-dependent reduction of ARID1B protein through proteasomal degradation), thereby relieving ARID1B-mediated repression of mTOR and stimulating milk fat/protein synthesis and proliferation in mammary epithelial cells.\",\n      \"method\": \"ARID1B knockdown/activation in HC11 cells, mTOR promoter ChIP/binding assays, cycloheximide/MG132/chloroquine inhibitor experiments, proliferation and lipid synthesis assays\",\n      \"journal\": \"Journal of Nutritional Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct promoter binding shown by ChIP plus degradation mechanism dissected; single lab\",\n      \"pmids\": [\"36681308\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Protein destabilization is the primary mechanism by which pathogenic missense mutations in ARID1B cause Coffin-Siris syndrome, as demonstrated by saturated mutagenesis screens; non-truncating mutations in the EHD2 (BRG1-interacting) and ARID domains cause protein misfolding and formation of cytoplasmic aggresomes (surrounded by vimentin, co-localizing with MTOC), with nuclear aggregates also forming for ARID domain variants, while protein levels are maintained.\",\n      \"method\": \"Saturated mutagenesis screen, overexpression assays with fluorescent reporters, western blot quantification, immunofluorescence for aggresome markers (vimentin, MTOC), genome-wide transcriptome and methylation analysis\",\n      \"journal\": \"Nature Structural & Molecular Biology / Human Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — saturated mutagenesis with multiple orthogonal mechanistic readouts in two independent studies\",\n      \"pmids\": [\"38347147\", \"39028335\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ARID1B controls chromatin accessibility at TCF-like, NFI-like, and ARID-like transcription factor binding regions in SATB2+ callosal projection neurons; ARID1B+/- neural organoids show impaired SATB2+ neuron maturation and reduced chromatin accessibility at these loci, causing transcriptional dysregulation of corpus callosum development genes and impaired long-range axonal projections.\",\n      \"method\": \"ARID1B+/- neural organoids, ATAC-seq, RNA-seq, in vitro corpus callosum tract model for axonal projection, SATB2 immunostaining\",\n      \"journal\": \"Cell Stem Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — ATAC-seq plus RNA-seq plus functional axon projection assay in patient-derived organoid model; multiple orthogonal methods\",\n      \"pmids\": [\"38718796\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ARID1B loss in the hematopoietic compartment impairs myeloid reconstitution in transplantation experiments and double ARID1A/ARID1B knockout causes acute bone marrow failure. ATAC-seq revealed that >80% of chromatin loci regulated by ARID1B are distinct from those regulated by ARID1A, with ARID1B controlling expression of genes crucial for myelopoiesis.\",\n      \"method\": \"Hematopoietic-specific conditional Arid1b knockout mice, bone marrow transplantation, ATAC-seq, RNA-seq\",\n      \"journal\": \"Blood Advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with transplantation readout and genome-wide chromatin profiling; well-controlled\",\n      \"pmids\": [\"37611161\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ARID1B maintains mesenchymal stem cell quiescence by suppressing BCL11B expression through direct binding to BCL11B's third intron; loss of ARID1B upregulates BCL11B, which in turn activates non-canonical Activin signaling (via INHBA/activin A and p-ERK), driving MSC proliferation. Reduction of BCL11B or inhibition of non-canonical Activin signaling restores MSC quiescence in Arid1b mutant mice.\",\n      \"method\": \"scRNA-seq, scATAC-seq of GLI1+ MSC lineage in Arid1b conditional KO mice, ChIP for ARID1B binding at Bcl11b intron, rescue experiments (Bcl11b reduction, Activin pathway inhibition), phospho-ERK immunostaining\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct binding shown by ChIP plus epistatic rescue experiments plus scRNA/scATAC-seq; multiple orthogonal methods\",\n      \"pmids\": [\"38816354\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ARID1B nuclear import is mediated by a KPNA2-KPNB1-RANBP2 cascade; specific residues R1518, H1519, and D1522 on ARID1B mediate interaction with KPNA2/KPNB1. Mutation of these residues attenuates the ARID1B-KPNA2/KPNB1 interaction and prevents ARID1B recruitment to the nuclear pore complex. Pharmacological inhibition of KPNB1 suppresses ARID1B nuclear translocation.\",\n      \"method\": \"Protein complex purification, mass spectrometry, site-directed mutagenesis of NLS residues, Co-IP, pharmacological KPNB1 inhibition, TNBC mouse xenograft models\",\n      \"journal\": \"Advanced Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — MS-identified complex, mutagenesis of interaction residues, pharmacological rescue, in vivo validation\",\n      \"pmids\": [\"40671262\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ARID1B knockdown in lung cancer cell lines impairs DNA damage repair, alters chromatin accessibility, and activates the cGAS-STING pathway, mechanistically linking ARID1B loss to innate immune signaling.\",\n      \"method\": \"siRNA knockdown, DNA damage assays (γH2AX foci, RAD51 foci), ATAC-seq for chromatin accessibility, cGAS-STING pathway marker analysis\",\n      \"journal\": \"Journal of Cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KD with multiple functional readouts (DNA repair, chromatin, innate immunity); single lab\",\n      \"pmids\": [\"38577613\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"mRNA display identified peptidic ligands that bind ARID1B with nanomolar affinity and high selectivity over ARID1A, engaging two distinct binding pockets; one pocket involves an ARID1B-exclusive cysteine residue that enables covalent targeting, providing first evidence of ARID1B ligandability.\",\n      \"method\": \"mRNA display peptide selection, biochemical binding assays, biophysical characterization (SPR/ITC), chemical biology pulldowns\",\n      \"journal\": \"ACS Chemical Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstituted binding with multiple orthogonal biophysical validations and covalent engagement demonstrated\",\n      \"pmids\": [\"38655884\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ARID1B is the largest DNA-binding subunit of the cBAF (canonical BAF/SWI/SNF) chromatin-remodeling complex, where it is mutually exclusive with its paralog ARID1A; it directly binds BRG1 via its EHD2 domain and DNA via its ARID domain, stabilizes the cBAF complex (loss of both ARID1A and ARID1B fully disassembles it), represses Wnt/β-catenin and mTOR transcription, promotes NHEJ-mediated DNA repair by recruiting the SWI/SNF ATPase to double-strand breaks, regulates interneuron progenitor proliferation and histone H3K9 acetylation at inhibitory neuron genes (Pvalb), controls the ARID1A→ARID1B subunit switch required for pluripotency exit during neural lineage commitment, maintains mesenchymal stem cell quiescence by repressing BCL11B/non-canonical Activin signaling, interacts with the lncRNA NEAT1 to couple paraspeckle function to chromatin regulation, and is imported into the nucleus via a KPNA2-KPNB1-RANBP2 cascade; cytoplasmic mislocalization of ARID1B instead activates RAF-ERK oncogenic signaling, and most pathogenic missense mutations cause protein misfolding and aggresome formation rather than loss of protein level.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"ARID1B is a dedicated, mutually exclusive DNA-binding subunit of the canonical BAF (cBAF) chromatin-remodeling complex that functions as a master epigenetic regulator of cell fate decisions, proliferation, and DNA repair across diverse lineages. It directly binds BRG1/SMARCA4 via its C-terminal EHD2 domain and DNA via its ARID domain (which harbors a unique β-sheet absent in ARID1A), stabilizes cBAF integrity—complete loss of both ARID1A and ARID1B disassembles the complex—and controls chromatin accessibility at lineage-specific loci including those governing pluripotency exit during neural crest specification (attenuating NANOG/SOX2 enhancers), GABAergic interneuron development (promoting H3K9ac at Pvalb), myelopoiesis, mesenchymal stem cell quiescence (repressing BCL11B/non-canonical Activin signaling), and erythropoiesis [PMID:11988099, PMID:34386776, PMID:34753942, PMID:29184203, PMID:37611161, PMID:38816354, PMID:35672450]. ARID1B additionally represses Wnt/β-catenin and mTOR transcriptional programs, promotes NHEJ-mediated DNA double-strand break repair by recruiting SWI/SNF to damage sites, and interacts with the lncRNA NEAT1 to couple paraspeckle function to chromatin regulation [PMID:26340334, PMID:36681308, PMID:24788099, PMID:36354291]. Pathogenic missense mutations in the ARID and EHD2 domains cause protein misfolding and aggresome formation rather than simple loss-of-function, and cytoplasmic mislocalization of ARID1B confers a gain-of-oncogenic function by activating RAF-ERK signaling; Coffin–Siris syndrome arises from ARID1B haploinsufficiency that disrupts the ARID1A-to-ARID1B subunit switch required for neural lineage commitment [PMID:38347147, PMID:33443092, PMID:34753942].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Identifying ARID1B as a direct BRG1-binding SWI/SNF subunit established its physical basis for chromatin-remodeling function and defined the EHD2 domain as the interaction surface.\",\n      \"evidence\": \"Co-immunoprecipitation with domain mapping and endogenous complex detection from mouse brain\",\n      \"pmids\": [\"11988099\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No genome-wide occupancy data\", \"Functional consequence of EHD1–EHD2 intramolecular interaction unknown\", \"No structural model of the ARID1B–BRG1 interface\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Demonstrating that biallelic ARID1B loss impairs ES cell self-renewal established that the ARID1B-containing BAF complex is required for maintaining pluripotency, not merely a structural component.\",\n      \"evidence\": \"Biallelic knockout in mouse ES cells with proliferation and gene expression analysis\",\n      \"pmids\": [\"18323406\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream gene targets not identified genome-wide\", \"Relationship to ARID1A-containing complexes not addressed\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Establishing mutual exclusivity with ARID1A and synthetic lethality upon dual loss resolved how the two paralogs partition cBAF function and revealed a therapeutically exploitable dependency in ARID1A-mutant cancers.\",\n      \"evidence\": \"RNAi in genetically defined cancer cell lines with Co-IP showing complex destabilization across multiple lines\",\n      \"pmids\": [\"24562383\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genomic targets uniquely controlled by ARID1B-BAF vs. ARID1A-BAF not defined\", \"Mechanism of complex destabilization not structurally resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Showing that ARID1B is required for KU70/KU80 recruitment to double-strand breaks and NHEJ efficiency expanded its role beyond transcription to DNA repair, explaining radiation and cisplatin sensitivity upon loss.\",\n      \"evidence\": \"Live-cell laser-induced DSB recruitment, NHEJ reporter assays, clonogenic survival after siRNA knockdown\",\n      \"pmids\": [\"24788099\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct physical contacts between ARID1B-BAF and NHEJ factors not mapped\", \"Relative contributions of ARID1A vs. ARID1B to repair not quantified\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrating that ARID1B associates with β-catenin via BRG1 and represses Wnt-dependent transcription linked the cBAF complex to a major developmental signaling pathway and explained neurite outgrowth phenotypes.\",\n      \"evidence\": \"Co-IP of ARID1B with β-catenin, luciferase Wnt reporters, domain-deletion mutants, siRNA phenotypes in neuroblastoma\",\n      \"pmids\": [\"26340334\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs. indirect β-catenin binding not distinguished\", \"Wnt target gene specificity not mapped genome-wide\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Placing ARID1B downstream of STAT3 and upstream of β-catenin in neurofibroma initiation demonstrated that ARID1B transcription is itself regulated by oncogenic signaling, creating a feedforward loop.\",\n      \"evidence\": \"Genetic epistasis with in vivo rescue in Stat3/Nf1 conditional KO mice, ChIP for histone modifications at Arid1b locus\",\n      \"pmids\": [\"26904939\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether STAT3 directly binds the Arid1b promoter not definitively shown\", \"Generalizability beyond Schwann cell lineage untested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Arid1b haploinsufficiency reducing cortical interneuron number through impaired progenitor proliferation and decreased H3K9ac at the Pvalb promoter provided the first epigenetic mechanism for ARID1B's role in excitatory/inhibitory balance and autism-like behavior.\",\n      \"evidence\": \"Arid1b+/- mice with BrdU proliferation, ChIP-H3K9ac, interneuron immunostaining, pharmacological GABAA rescue\",\n      \"pmids\": [\"29184203\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ARID1B directly binds the Pvalb promoter or acts indirectly not resolved\", \"Genome-wide H3K9ac changes not profiled in interneurons specifically\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Systematic analysis of dual ARID1A/ARID1B loss showed that residual cBAF subcomplexes poison pBAF function and that 37/69 cancer-derived ARID1 mutations disassemble the complex, unifying oncogenesis mechanisms across tissues.\",\n      \"evidence\": \"Double-KO mouse models (liver, skin), add-back in endometrial cancer cells, biochemical complex analysis of 69 clinical mutations\",\n      \"pmids\": [\"34386776\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of subcomplexes disrupting pBAF not solved\", \"Whether residual subcomplexes have neomorphic chromatin activities unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Demonstrating the ARID1A→ARID1B subunit switch during neural crest specification, and its failure in Coffin–Siris patient iPSCs, established that the disease arises from impaired lineage commitment rather than simple proliferative defects.\",\n      \"evidence\": \"ChIP-seq for ARID1A/ARID1B occupancy, ATAC-seq, RNA-seq in patient iPSC-to-neural-crest differentiation\",\n      \"pmids\": [\"34753942\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signal that triggers the subunit switch not identified\", \"Whether switch occurs in non-neural lineages not tested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Discovering that cytoplasmic mislocalization of ARID1B activates RAF-ERK signaling via direct c-RAF binding revealed a gain-of-function oncogenic mechanism distinct from nuclear loss-of-function.\",\n      \"evidence\": \"NLS mutant construction, Co-IP with RAF1/PPP1CA, xenograft assays, pancreatic tumor TMA\",\n      \"pmids\": [\"33443092\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and structural basis of cytoplasmic ARID1B–RAF1 complex unknown\", \"Frequency of NLS mutations in patient cohorts not systematically assessed\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identification of ARID1B as a direct NEAT1-binding partner coupling paraspeckles to chromatin regulation expanded the functional repertoire of cBAF beyond protein-mediated recruitment to include lncRNA-dependent targeting.\",\n      \"evidence\": \"Co-IP, RNA pulldown, mass spectrometry interactome, RNA-seq/splicing analysis after ARID1B or NEAT1 depletion\",\n      \"pmids\": [\"36354291\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"RNA-binding domain on ARID1B not mapped\", \"Whether other lncRNAs similarly recruit cBAF not tested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"NMR and ITC characterization of the ARID domain revealed a unique β-sheet element and distinct DNA-binding thermodynamics compared to ARID1A, providing a structural basis for paralog-specific target recognition.\",\n      \"evidence\": \"NMR backbone assignment, chemical shift perturbation mapping, ITC, HADDOCK docking\",\n      \"pmids\": [\"35481652\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No co-crystal structure with DNA\", \"How structural differences translate to genomic locus specificity not demonstrated\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Saturated mutagenesis showed that most pathogenic Coffin–Siris missense mutations cause protein misfolding and aggresome formation rather than reduced expression, redefining the disease mechanism as a proteostasis defect.\",\n      \"evidence\": \"Saturated mutagenesis screen, fluorescent reporters, aggresome marker immunofluorescence, genome-wide methylation analysis\",\n      \"pmids\": [\"38347147\", \"39028335\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether aggresomes sequester other BAF subunits not tested\", \"Contribution of aggresome toxicity vs. nuclear depletion to phenotype not dissected\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defining ARID1B's chromatin targets in callosal projection neurons (SATB2+) and myeloid progenitors, with >80% non-overlapping with ARID1A targets, established paralog-specific chromatin programs in vivo.\",\n      \"evidence\": \"ATAC-seq/RNA-seq in ARID1B+/- neural organoids and hematopoietic-specific Arid1b KO mice with transplantation\",\n      \"pmids\": [\"38718796\", \"37611161\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct ARID1B ChIP-seq in these lineages not performed\", \"Mechanism selecting ARID1B vs. ARID1A for distinct loci unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Mapping the KPNA2-KPNB1-RANBP2 nuclear import pathway for ARID1B and identifying critical NLS residues resolved how ARID1B reaches the nucleus and provided a pharmacologically targetable transport mechanism.\",\n      \"evidence\": \"MS-based complex identification, site-directed mutagenesis of R1518/H1519/D1522, KPNB1 inhibitor, xenograft models\",\n      \"pmids\": [\"40671262\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ARID1A uses the same import pathway not determined\", \"Therapeutic window of KPNB1 inhibition not established\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identification of ARID1B as a repressor of BCL11B/non-canonical Activin signaling in mesenchymal stem cells established a new lineage context (MSC quiescence) and defined a complete epistatic circuit from chromatin to secreted ligand.\",\n      \"evidence\": \"scRNA-seq/scATAC-seq of GLI1+ MSCs, ChIP at Bcl11b intron, epistatic rescue with Bcl11b reduction and Activin inhibition\",\n      \"pmids\": [\"38816354\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether this circuit operates in other quiescent stem cell populations unknown\", \"Direct ARID1B binding mechanism at intronic element not structurally resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: what signal triggers the ARID1A-to-ARID1B subunit switch, how paralog-specific genomic targeting is achieved at the structural level, whether aggresome formation contributes to Coffin–Siris pathology through toxic gain-of-function or purely through nuclear depletion, and the full catalog of lncRNAs that recruit ARID1B-cBAF to chromatin.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structure of full-length ARID1B or ARID1B-nucleosome complex\", \"Cis-regulatory logic determining ARID1B vs. ARID1A locus selection unknown\", \"Relative contribution of aggresome toxicity vs. nuclear loss in CSS not tested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [21, 25]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [20]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [6, 10, 23, 27]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3, 13, 18]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 16, 17, 28]},\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [10, 25]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [18, 24]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [0, 3, 10, 17, 25, 26]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [4, 29]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [6, 8, 18, 23, 27]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [6, 10, 17, 23, 27]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [9, 10, 14, 17, 25]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [2, 5, 7]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [13, 18, 24]}\n    ],\n    \"complexes\": [\n      \"cBAF (canonical BAF/SWI/SNF)\"\n    ],\n    \"partners\": [\n      \"SMARCA4\",\n      \"CTNNB1\",\n      \"RAF1\",\n      \"NEAT1\",\n      \"KPNA2\",\n      \"KPNB1\",\n      \"PPP1CA\",\n      \"BCL11B\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}